In NSCLC, chemotherapeutic agents such as adriamycin [43], 9‐nitrocamptothecin (9NC) [43], gemcitabine [44], and cisplatin [45] have been reported to upregulate RKIP as part of their mechanism of action, promoting apoptosis. This evidence concerns the gene PEBP1 and non-small cell lung carcinoma.